Seven directors of 23andMe resigned from the genetic test company's board Tuesday amid co-founder and CEO Anne Wojcicki's attempt to buy out existing shareholders and take the company private.

All seven independent directors of 23andMe resigned from the board, citing disagreements with CEO Anne Wojcicki regarding the ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...

All seven members of 23andMe’s board resigned in a stinging rebuke to a proposal by CEO Anne Wojcicki’s plans to to take the ...

23andMe Holding Co. co-founder and Chief Executive Officer Anne Wojcicki told employees that she remains committed to taking the genetic testing company private following the resignation of its ...

Sep 12, 2024, 9:22am EDT Updated: Sep 12, 2024, 9:47am EDT Kimberly White/Getty Images for Breakthrough Prize 23andMe CEO Anne Wojcicki, astrophysicist Jocelyn Bell Burnell and philanthropist ...

All seven independent directors of 23andMe resigned from the company's board Tuesday, a move that CEO Anne Wojcicki said left her "surprised and disappointed," according to a memo to employees.

In a memo to employees, CEO Anne Wojcicki said she was "surprised and disappointed by the decision." All seven independent directors of 23andMe resigned from the company's board Tuesday ...

following a protracted negotiation with founder and Chief Executive Anne Wojcicki over her plan to take the company private. It is the latest challenge for 23andMe, which has struggled to find a ...

DNA-testing company 23AndMe and its founder, Anne Wojcicki, aimed to revolutionize healthcare, bringing genetic tests into homes with just a tube of spit. WSJ takes a look at the factors that have ...

Wojcicki, who has been trying to take the company private since April, proposed to acquire all outstanding shares of 23andMe not owned by her or her affiliates for $0.40 per share, in July.